The Principle of Risk-Based Classification

EU MDR Annex VIII establishes a set of classification rules based on the risk the device poses to patients and users. The classification rules consider: the intended purpose of the device, the nature of contact with the body (non-invasive, invasive, implantable), the duration of body contact (transient <60 min, short-term 60 min–30 days, long-term >30 days), the part of the body affected (skin surface, mucous membrane, circulatory system, central nervous system), and whether the device is active (powered) or non-active. Correct classification requires systematic analysis of the device's intended purpose against each applicable classification rule — not an intuitive guess.

Class I: Lowest Risk

Class I devices are the lowest risk category and include most non-invasive devices, simple surgical instruments, and dressings. Examples: examination gloves, bandages, wheelchairs, hospital beds, corrective glasses, stethoscopes, non-sterile surgical instruments. Class I self-declaration: the manufacturer declares conformity without Notified Body involvement — creating a Technical File and Declaration of Conformity is required. Class I sterile (Is): sterile packaging must be assessed by a Notified Body (for the sterility aspect only). Class I measuring (Im): measuring function must be assessed by a Notified Body. Class I reusable surgical instruments (Ir): the reprocessing aspects are assessed by a Notified Body. Note: MDR reclassified many previously Class I devices (e.g., suction catheters, certain wound dressings) to Class IIa or higher — manufacturers should recheck all Class I classifications against MDR rules.

Class IIa: Low-Medium Risk

Class IIa devices are low-to-medium risk devices and typically include short-term invasive devices, active devices for diagnosis and therapy, and devices in contact with mucous membranes or certain body fluids. Examples: surgical gloves, dental instruments, hearing aids, ultrasound scanners, infusion pumps, endoscopes (non-implantable), blood glucose meters. Class IIa conformity assessment requires Notified Body involvement — either QMS assessment (Annex IX) or Type Examination + Production QA (Annex XI). A full Technical Documentation assessment is not required for all Class IIa devices — the NB assesses a representative sample. The PSUR must be updated every 2 years.

Class IIb: Medium-High Risk

Class IIb devices are medium-to-high risk devices with more significant patient contact or therapeutic effect. Examples: ventilators, anaesthesia machines, infusion pumps for high-risk drugs, X-ray equipment, orthopaedic implants (non-active), long-term implantable contraceptive devices, haemodialysis equipment. Class IIb conformity assessment requires more intensive Notified Body involvement — for most Class IIb devices, the NB must assess the Technical Documentation for at least one representative device per category. PSURs must be updated annually. PMCF is typically mandatory. Note: certain Class IIb implantable devices trigger the EU MDR Article 54 scrutiny procedure, adding an additional EU clinical expert consultation to the certification timeline.

Class III: Highest Risk

Class III devices are the highest risk category, typically those that interact with the central circulatory or nervous system, are absorbed by the body, or present the highest risk of serious patient harm. Examples: cardiac stents, heart valves, total joint replacement implants, spinal implants, active implantable devices (pacemakers, cochlear implants), drug-eluting devices, devices composed of substances absorbed by the body. Class III conformity assessment requires the most rigorous NB involvement: full Technical Documentation assessment for each device, clinical investigation typically required if no equivalent device exists, annual PSUR updates, mandatory PMCF with patient-level outcome data, and for certain device types, the Article 54 scrutiny procedure involving EU clinical expert panels.

Classification Rules: The Most Commonly Applied

The most commonly applied MDR classification rules are: Rule 1 (all non-invasive devices — Class I unless subsequent rules apply), Rule 5 (invasive devices used in body orifices — Class IIa for short-term, IIb for long-term), Rule 6 (surgically invasive devices for transient use — Class IIa, with exceptions to IIb and III), Rule 7 (surgically invasive devices for short-term use — Class IIa, with exceptions), Rule 8 (implantable and long-term surgically invasive devices — Class IIb, with specific exceptions to III), Rule 9 (active therapeutic devices — Class IIa or IIb depending on energy delivery), Rule 11 (software — classified by the severity of potential harm from incorrect function). Rule 11 (software classification) is particularly important for manufacturers of software-embedded medical devices and Software as a Medical Device (SaMD).

Classification Challenges and Common Errors

The most common MDR classification errors include: (1) Applying MDD classification rules instead of MDR rules — MDR Annex VIII rules changed significantly from MDD Annex IX, resulting in reclassification of many devices; (2) Ignoring the intended purpose — classification is based on the manufacturer's stated intended purpose, not solely on physical device characteristics; (3) Incorrect duration assessment — a device used for up to 60 minutes is transient, not short-term; errors here affect Rule 5 and 7 classifications; (4) Missing the combination device rule — if a device incorporates a medicinal substance or is presented together with one, higher classification rules apply; (5) Software not separately classified — software embedded in a device must be classified under Rule 11 in addition to the overall device classification.

Conclusion

Correct MDR classification is the foundation of the entire CE marking process. Turkish medical device manufacturers should conduct a formal classification review under MDR Annex VIII rules for every product they intend to export to the EU — particularly if those products were previously classified under MDD, as many devices have been reclassified under MDR. When classification is uncertain, consultation with a regulatory affairs specialist or the chosen Notified Body at an early stage prevents costly and time-consuming reclassification issues later in the certification process.